Match each clinical scenario involving a patient with an anxiety, obsessive-compulsive, or trauma-related disorder to the most appropriate next step in pharmacological management.
- A 35-year-old with PTSD has achieved remission of daytime hyperarousal on maximal-dose sertraline but continues to experience frequent, highly distressing trauma-related nightmares.Add an alpha-1 adrenergic antagonist (e.g., prazosin)
- A 29-year-old with Generalized Anxiety Disorder requests a daily maintenance medication but adamantly refuses SSRIs and SNRIs due to a history of severe medication-induced sexual dysfunction.Initiate buspirone maintenance therapy
- A 22-year-old with severe OCD has achieved only a minimal reduction in symptoms after 14 weeks of high-dose fluoxetine combined with rigorous exposure and response prevention therapy.Augment with an atypical antipsychotic (e.g., aripiprazole)
- A 41-year-old with Panic Disorder and a recent history of severe alcohol use disorder requires short-acting symptomatic relief for acute panic attacks while awaiting the full onset of a newly initiated SSRI.Prescribe an antihistamine (e.g., hydroxyzine) as needed
Cevap
The scenarios match with their management steps as follows: PTSD with nightmares matches alpha-1 antagonist addition; GAD with SSRI-induced sexual dysfunction matches buspirone; treatment-resistant OCD matches atypical antipsychotic augmentation; and Panic Disorder in a patient with SUD matches as-needed antihistamine.
Each clinical scenario requires a specific nuance in psychopharmacology. PTSD nightmares respond well to alpha-1 blockade (prazosin). GAD requiring non-sexual-dysfunction-inducing therapy is best managed with buspirone. SSRI-resistant OCD benefits from atypical antipsychotic augmentation. Acute panic in patients with substance use disorders requires non-addictive PRN agents like hydroxyzine.
Adım Adım Çözüm
Anahtar Kavram
Pharmacological management of anxiety, OCD, and trauma-related disorders requires tailoring interventions based on specific residual symptoms, medication side effect profiles, treatment resistance, and comorbid substance use disorders.